InSilico Medicine (HKG:3696) said Monday it will collaborate with an unnamed AI lab to develop frontier models to support biological research under a contract valued at up to tens of millions of U.S. dollars, according to a same-day filing with the bourse.
The duo will leverage InSilico's MMAI Gym training framework and data from its previous scientific studies, and will share revenue under the terms of their agreement, which the company did not disclose.
InSilico's shares were last up 4% on the HKEX.